AIXA AIXTRON SE
AIXTRON SE, together with its subsidiaries, manufactures and sells deposition equipment to the semiconductor industry in Asia, Europe, and the United States. The company offers G10-SiC, G10-GaN, G10-AsP, AIX G5+ C, Closed Coupled Showerhead systems for research and development, AIX 2800G4-TM, and AIX G5 WW C. It also develops, produces, and installs equipment for the deposition of semiconductor materials; and offers deposition processes, consulting, training, customer support, and other related services, as well as peripheral equipment and services to support the operation of its systems. In addition, the company engages in supplying deposition equipment for volume production; and research and development and pre-series production activities. Its products are used in laser, LED, display technologies, optical data transmission, SiC and GaN power electronics, and other applications. AIXTRON SE was founded in 1983 and is headquartered in Herzogenrath, Germany.…
Industry Peers
Semiconductor Equipment & MaterialsKey Statistics
About AIXTRON (ETR: AIXA)
›
AIXTRON (ETR: AIXA) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Semiconductor Equipment & Materials industry, part of the Technology sector, and reports about 996 employees.
The shares were at 32.51 EUR on 19 November 2026, up 82.9% over 52 weeks. Its 52-week range is 16.07 EUR to 62.66 EUR: the price is 48.1% below the high and 102.3% above the low.
At a market capitalisation of 3.67B EUR, it trades at 45.2 times trailing earnings and 21.0 times forward earnings. The median trailing P/E of its 19 largest Semiconductor Equipment & Materials peers is 34.7, a premium of 30% for AIXA. It pays a dividend yielding 0.48% (it pays out 21% of its earnings), against a median of 0.61% among the dividend payers in that peer group.
AIXTRON reports return on equity of 9.4%, an operating margin of 20.0% and revenue up 53.6% year over year.
It holds more cash than debt, a net cash position of 587.44M EUR. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 15 analysts cover the stock, with an average rating of Buy; their mean price target of 47.45 EUR is 45.9% above the current price. The next earnings report is expected on 4 March 2027.